SingaporeOverview
Financial Performance
Business Operations & Assets
Business Details
Reason For Sale
Description
Australian pharmaceutical company with world first treatment for heart disease is experiencing massive demand for their life saving treatment.
Sales potential in the USA alone is worth over $60 billion annually.
Urgent investment funds are required to expand production to meet the massive demand for our product.
Investors can expect over 20 times return on investment within 6 months.
Only 20 investment shares available at $50,000 each.
Please respond to receive our investment proposal.
This is a unique opportunity and will be snapped up quickly.
Listing information is provided by the listing provider or their representatives and has not been independently verified by our platform. Users should verify all information and conduct their own due diligence before making any decision, payment or commitment.
All communications, agreements, transactions, disputes and claims are solely between the relevant parties.
Learn how to avoid scams